News

Pfizer invests $35M in biotech company | Health IT

By October 18, 2022No Comments

Pfizer has made a $35 million investment — through its Pfizer “Breakthrough Growth Initiative” — in autoimmune disease treatment biotechnology company Anokion.Health IT

Leave a Reply Cancel Reply

The Washington Metropolitan Area Chapter(WMAC) of the National Association of Health Services Executives (NAHSE) was chartered in 1978 to educate and develop minority healthcare leaders while, in conjunction with the American College of Healthcare Executives (ACHE), promoting C-Suite diversity for Healthcare Organizations throughout Northern Virginia, Southern Maryland, and the District of Columbia. The Washington Metropolitan Area Chapter (WMAC) was one of the first two chapters founded by the Association, since its inception.

Pfizer invests $35M in biotech company | Health IT

Tags:

Previous PostFertility-focused software company raises $11M | Health IT

Next PostWearables have a long way to go before being useful medical tools | Health IT

Leave a Reply Cancel Reply

Join the NAHSE-WMAC Mailing List

Contact Us